Insufficient Milk Supply and Breast Cancer Risk: A Systematic Review by Cohen, Jacqueline M. et al.
Insufficient Milk Supply and Breast Cancer Risk: A
Systematic Review
Jacqueline M. Cohen
1, Jennifer A. Hutcheon
1, Sofi G. Julien
2, Michel L. Tremblay
2,3, Rebecca Fuhrer
1*
1Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada, 2Goodman Cancer Centre, McGill University,
Montreal, Quebec, Canada, 3Department of Biochemistry, McGill University, Montreal, Quebec, Canada
Abstract
Background: An association between insufficient milk supply, the inability of a mother’s breast milk to provide sufficiently
for her infant, and breast cancer has been suggested by observations in animal models. To determine if an association has
been reported in epidemiological studies of human breast cancer, a systematic review of the literature has been conducted.
We also sought to identify the methodological limitations of existing studies to guide the design of any future prospective
studies in this field.
Methodology/Principal Findings: PubMed, EMBASE, Web of Science, BIOSIS, and CAB abstracts were searched. We selected
any study that (1) assessed breast cancer in association with breastfeeding history and (2) examined the relationship
between insufficient milk supply with breast cancer. Seven relevant studies were identified that met both criteria. There was
statistically significant heterogeneity among the results which likely reflects clinically significant differences in definitions of
insufficient milk supply and reference groups that were used. Among premenopausal women who had experienced
insufficient milk supply, odds ratios (ORs) for breast cancer risk ranged from 0.9 to 16.3. Among postmenopausal women,
ORs ranged from 0.6 to 6.7. Based on the range of odds ratios obtained in the studies reported in this review, it remains
unclear if there is a true association between insufficient milk supply and breast cancer.
Conclusions/Significance: Although some studies have shown a strong positive association, there is no consistent evidence
for an effect of insufficient milk supply on breast cancer risk. Exposure definitions are in need of improvement in order to
focus on primary insufficient milk supply. Reference groups consisting of women who have successfully breastfed may also
introduce positive bias (inflation of the odds ratio) into study results because of the protective effect of prolonged
breastfeeding in the control group.
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Introduction
In North America, breast cancer is the second leading cause of
cancer-related death in women [1]. Because of the relatively lower
percentage of breast cancer cases at younger ages (4% of cases and
2% of all breast cancer deaths among Canadian women ages 20–
39 [2]), young women are not typically screened for breast cancer.
However, a systematic review of long term survival (10+ years)
after breast cancer found that younger age usually entails a more
deadly cancer [3]. Further, epidemiological studies have shown
that breast cancer diagnosed in close proximity to last birth shows
poorer prognosis [4].
Recent evidence from a murine model of breast cancer has
suggested there may be a link between breast tumours and
insufficient maternal milk supply. Using a well established breast
cancer model (in which mammary tumour formation [5] is
produced by overexpression of an activated form of the ErbB2
gene), it was observed that mice that are at risk for breast tumours
also experience the inability to produce enough milk to support the
survival of their offspring.
In many ErbB2 overexpressing cell lines, a protein tyrosine
phosphatise, PTP1B, is concomitantly increased in expression [6].
Tremblay’s group has recently demonstrated that overexpression
of PTP1B in the murine mammary gland causes tumour formation
[7]. The phenotype that was observed from mice overexpressing
ErbB2 and PTP1B was insufficient mammary glandular develop-
ment during pregnancy which caused the majority of the offspring
to die (10% survival). However, when the transgenic mice
overexpressing an activated form of ErbB2 were crossed with a
PTP1B knockout, it was observed that mammary gland develop-
ment was almost fully restored to normal and 85% of the pups
survived with weights close to the control litters [8].
These observations in mice have led our group to develop a
common cause hypothesis that asserts that misexpression of
PTP1B, and potentially of other genes causing defects in breast
development, may not only cause difficulties in breastfeeding but
could also lead to increased risk for breast tumour formation and
cancer progression. If this hypothesis is correct, PTP1B could
potentially be a novel biomarker for existing breast cancer or
future risk among pregnant or lactating women, especially for
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the intrinsic incapacity of the breast to produce milk due to
inadqequate breast development. However, before a prospective
study evaluating this hypothesis in humans is conducted, an
understanding of existing work in this field is needed.
Several review articles addressing breastfeeding and breast
cancer risk have mentioned an association between insufficient
milk supply and subsequent breast cancer [9–11]; however it is
imperative that a rigorous survey of the literature be carried out on
this question. The evidence from such a review can help determine
the need for further epidemiologic studies and contribute to
incorporating the lessons learned from previous work into future
studies.
The objectives of this study were 1) to systematically review the
literature that addresses the question: among parous women, is
insufficient milk supply during lactation associated with an
increased risk of breast cancer? and 2) to identify the methodo-
logical or study design limitations of existing studies in order to
guide the design of any future prospective studies in this field.
If insufficient milk supply were caused by elevated PTP1B, or
other new biomarkers, then this persistent overexpression would
most likely cause cancer in the short-term. It seems unlikely from
the current evidence [7] that PTP1B could be elevated in the
breast tissue for many years without causing a malignancy.
Although we cannot exclude the possibility that a link between
insufficient milk supply and breast cancer could be associated with
postmenopausal breast cancer, we hypothesize that an association
would more likely be found among premenopausal breast cancer
patients.
Materials and Methods
Search Strategy
Our goal was to collect relevant studies that examined the risk of
breast cancer in relation to breastfeeding history. We first included
studies identified in a systematic review by Berrino et al. done for
the WCRF/IACR that encompassed a variety of risk factors for
breast cancer, including lactation history [12]. These breast cancer
researchers designed a search strategy which was included in a
peer-reviewed protocol for their systematic review. The team
identified studies from 1966-January 2006 that addressed breast
cancer risk in relation to breastfeeding from a variety of electronic
databases. We further extended their list of relevant investigations
by compiling the most recent studies published during the period
of February 2006 to August 8, 2008. Databases included in the
search were MEDLINE via PubMed, and EMBASE, ISI Web of
Science, BIOSIS, and CAB abstracts via Ovid. The initial search
strategy was developed for PubMed and then it was adapted to the
other databases. The primary search in PubMed included the
following text words in the title or abstract as well as subject
headings: (‘‘breast feeding’’[MeSH] OR ‘‘breast feeding’’[tiab]
OR ‘‘breastfeeding’’[tiab]) AND ((mammary AND (cancer* OR
neoplasm* OR tumour* OR tumor* OR carcinoma* OR
adenocarcinoma*)) OR (Breast AND (cancer* OR neoplasm*
OR tumour* OR tumor* OR carcinoma* OR adenocarcinoma*))
OR ‘‘Breast Neoplasms’’[MeSH]). The searches were limited to
English language studies.
Study Selection
Our search results underwent a primary screen of titles and
abstracts to identify any recent study that addressed breast cancer
risk in relation to lactation history or more broadly, ‘reproductive
factors.’ Any study identified in the primary screen as potentially
eligible for inclusion then was assessed in a full-text screen
according to predetermined inclusion and exclusion criteria. The
inclusion criteria were intentionally broad so that it would be
possible to include all evidence that exists, regardless of the study
quality, sample size, or other factors. The articles identified in the
breast cancer review by Berrino’s team were included in the
secondary, full-text screen.
The secondary screen of all papers from 1966–2008 that
addressed lactation and breast cancer aimed to identify any study
that examined an association between insufficient milk supply and
breast cancer. For inclusion eligibility, studies must have provided
odds ratios (ORs) and 95% confidence intervals (CIs) for estimates
of risk of breast cancer associated with insufficient milk supply or
data necessary for calculation of unadjusted ORs and 95% CIs.
We limited our review to English language studies, and excluded
editorials, letters to the editor, conference abstracts, review articles,
and meta-analyses were excluded. Studies were also excluded if
there was no measure of the relationship between the risk factor
and breast cancer reported in the journal article.
Data Abstraction
Relevant data were independently extracted by two investiga-
tors (J.M.C. and J.A.H.) through use of a data extraction form that
was tailored for the review and improved via several pilot
extractions. Collected data include basic study characteristics such
as location and time period, sources of study subjects, age groups
included, and other information about study design, including case
definitions and participation rates. To elucidate the information
that is important for judging study quality, we included a section
based on the STROBE statement [13], where each paper could be
assessed according to specific items defined in the STROBE
statement checklist (http://www.strobe-statement.org/Checklist.
html). Finally, results from each study were recorded. These
included raw data and crude ORs as well as adjusted ORs, when
available, and the potential confounders that were adjusted for in
each study.
Extracted data were compared and disagreements were resolved
by consensus. Agreement on several predetermined items was
assessed to determine inter-rater reliability: Table 1 depicts these
specific questions and items. The investigators specified that the
raw data to be recorded should reflect the comparisons that were
utilized in the authors’ analyses, even when data for multiple
reference groups were sometimes available.
Study Quality Assessment
Study quality was assessed according to the items identified in
the STROBE statement for reporting of observational studies. An
item that assessed interviewer blinding was added to the adapted
checklist as it is an important quality factor in case-control studies.
All items were assessed on a yes/no basis, except for case
ascertainment. Quality was assessed subjectively by addressing
what were considered by the reviewers to be the most important
items related to study quality. These items include participation
rate, mean time between diagnosis and interview, reporting of
sample size calculation, breast cancer assessment method,
interviewer blinding, reporting of missing data, and quality of
exposure definition which was addressed based on previous
research regarding breastfeeding difficulties.
Statistical Analysis
Crude ORs and 95% CIs were calculated for the association
between insufficient milk supply and breast cancer for each study
according to the raw data presented in the report. Heterogeneity
between studies was assessed with the I
2 test, a measure of
variability related to heterogeneity as opposed to chance. Values
Milk Supply and Cancer Risk
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2 test range from 0–100%; 0–25%, .25–50%, and .50–
75% correspond to low, moderate and high heterogeneity [14].
Meta-analysis was performed using a random-effects model to
pool study estimates of effect. Heterogeneity was calculated for
estimates of pre- and postmenopausal breast cancer risk separately
and meta-analysis was used to pool effect estimates for pre- and
postmenopausal breast cancer separately. Meta-analysis was only
performed if there were three or more studies available for
comparison.
After examining the studies to be included, it became apparent
that the use of different reference groups slightly altered the
research question and therefore, the conclusions that could be
drawn from the results. Due to the comparisons with multiple
reference groups, studies were stratified based on three broad
comparison groups of parous women: 1) successfully breastfed, 2)
unsuccessful at breastfeeding for reasons other than insufficient
milk supply, and 3) never breastfed. Due to concerns of unadjusted
confounding, meta-analysis was not performed on the data
comparing women with insufficient milk supply to those women
who never breastfed. Meta-analyses of crude and adjusted results
were performed separately. Statistical analyses were performed
using STATA/SE 10.0 software (STATA, College Station, TX,
USA).
Results
The combined searches of Berrino et al. and our group (i.e.
1966–2008) yielded 120 articles for the full-text secondary screen
(Figure 1). Seven studies were identified in this secondary screen
that provided estimates of the effect of insufficient milk on breast
cancer risk (Table 2) [15–21]. The primary reason for exclusion
of studies during the full-text screen was that they did not provide
data on our primary research question. Few studies asked
subjects why they had discontinued breastfeeding or if they had
experienced difficulties breastfeeding. Three studies were ex-
cluded in the secondary screen which reported in their methods
that they had asked study subjects about reasons for breastfeeding
cessation in the interview, but did not report any data related to
insufficient milk supply or breastfeeding difficulties in general
[22–24].
For data extraction, the average number of items that were in
agreement was 7.3 out of the 9 pre-specified items (81%).
Reviewers discussed disagreements and they were resolved by
consensus. Agreement on raw data necessary for calculation of
crude ORs and the reported adjusted ORs was 100%.
General Characteristics of Studies
The crude and adjusted ORs for the risk of breast cancer among
women with insufficient milk supply are summarized in Table 3
(premenopausal breast cancer) and Table 4 (postmenopausal
breast cancer) according to the reference group selected in the
study. Table 3 and Table 4 also provide more specific details about
the reference groups that were used for each comparison as well as
the various definitions of insufficient milk supply that were
employed in each study.
Exposure to insufficient milk supply was entirely self-reported.
While most studies specified the post-partum time period for
which insufficient milk supply could be considered the cause of
breastfeeding cessation, Byers’ did not. Many women may
mistakenly report physiologic declines in milk supply several
months after delivery as insufficient milk supply if the time period
is unspecified. The definition employed in the Newcomb studies
may also include some of these women. It would be preferable to
restrict the time period for which insufficient milk supply can be
reported, for example for the first 1 month after delivery, as a
woman who is unable to provide sufficient nutrition to her infant
will most likely not continue breastfeeding for much longer.
Brinton’s definition of the exposure identified in the first two weeks
after delivery is probably too limited. Many of these women could
have had other explanations for their breastfeeding difficulties and
did not explore the root cause as intensively as others who were
more persistent in their attempts to successfully breastfeed.
Figure 2 presents forest plots showing the crude and adjusted
ORs for the risk of breast cancer among premenopausal women
(left) and postmenopausal women (right) who experienced
insufficient milk supply as compared to successful breastfeeding,
except in the case of Brinton et al. where this reference group was
not available. The studies are ranked roughly in order of the
quality of the exposure definition, with the highest quality
exposure definitions towards the bottom of each plot. We observe
that as the definition of insufficient milk supply becomes more
focused on the small percentage of women who cannot successfully
breastfeed because of inadequate mammary gland development,
the ORs for the risk of breast cancer increase.
Brinton et al. identified premenopausal women who had
stopped breastfeeding within 2 weeks of delivery [18]. They
compared those who stopped because of insufficient milk to
women who stopped for other reasons. From the raw data that
they presented, we calculated the OR to be 1.5 (95% CI: [0.7, 3.6]).
Yang et al.’s data allowed for a similar comparison. We used their
raw data to compare women who breastfed unsuccessfully (,1
Table 1. Items used to assess inter-rater reliability for data extraction.
Questions and items
1 Did the authors state any specific objectives?
2 Did the authors give eligibility criteria and sources and methods of case ascertainment and control selection? Did they give the rationale for choiceo f
cases and controls?
3 Did the authors clearly define exposures and outcomes?
4 Potential confounders (list of check boxes)
5 For each variable, did the authors give sources of data and details and methods of assessment?
6 Did the authors describe all statistical methods, including those used to control for confounding?
7 Did the authors report the number of individuals at each stage of the study?
8 Did the authors indicate the number of study participants with missing data?
9 Raw data for 262 tables and adjusted odds ratios
doi:10.1371/journal.pone.0008237.t001
Milk Supply and Cancer Risk
PLoS ONE | www.plosone.org 3 December 2009 | Volume 4 | Issue 12 | e8237month) because of insufficient milk to women who were
unsuccessful for other reasons [20]. The OR for this comparison
was 1.0 (95% CI: [0.3, 3.7]) for premenopausal cases of breast
cancer and 1.1 (95% CI: [0.5, 2.2]) for postmenopausal breast
cancer.
Premenopausal Breast Cancer
Studies that compared premenopausal women who had
experienced insufficient milk supply to those who had successfully
breastfed had crude ORs ranging from 1.0 to 16.3 (Figure 2). Two
studies obtained confidence intervals that included the null value
of the OR and the other three studies’ confidence intervals all
exceed the null value, suggesting a possible effect. These results
were highly heterogeneous; the I
2 was 78% (95% CI: [46, 91%]),
indicating that most of the variability is due to heterogeneity rather
than chance. It is clear just by looking at the forest plot that the
results are not consistent, but suggest a possible association. When
adjusted estimates of the association between insufficient milk and
premenopausal breast cancer were examined, ORs ranged from
0.9 to 3.1, and only Yang’s study (which obtained an adjusted OR
of 3.1) reported a 95% CI that excluded the null value [20]. These
results were also highly heterogeneous; the I
2 was 73% (95% CI:
[11, 92%]). According to the random effects models, the pooled
estimate of the crude OR was 2.0 (95% CI: [1.0, 3.9]) and the
adjusted OR was 1.4 (95% CI: [0.7, 2.9]).
Postmenopausal Breast Cancer
Studies that compared postmenopausal women who had
experienced insufficient milk supply to those who had successfully
breastfed found crude ORs ranging from 0.7 to 6.7, and only the
95% CI from Shema’s study which reported an OR of 6.7
excluded the null value [15]. These results were highly
heterogeneous; the I
2 was 84% (95% CI: [67, 92%]). When
adjusted ORs were compared for postmenopausal breast cancer,
Figure 1. Flow diagram for study selection. Studies from 1966-Jan. 2006 that addressed an association between breastfeeding history and
breast cancer were obtained from a systematic review of breast cancer that addressed various risk factors. To obtain studies from Feb. 2006-present,
we developed a search strategy that was based on that which was employed by the existing review. All studies from 1966-present were assessed for
inclusion in this systematic review. Dashed lines surround the work that was previously published by Berrino, et al.
doi:10.1371/journal.pone.0008237.g001
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2 was low, and adjusted ORs
ranged from 0.6 to 1.6. The I
2 was 24% (95% CI: [0, 88%]). All of
the CIs for the adjusted ORs included OR=1, suggesting no
effect. According to the random effects models, the pooled
estimate of the crude OR was 1.2 (95% CI: [0.9, 1.7]) and the
adjusted OR was 0.9 (95% CI: [0.8, 1.1]).
Discussion
Main Findings
This systematic review assessed the literature on the risk of
breast cancer after experience of insufficient milk supply and has
revealed that there has been interest in the question, but studies to
date have not brought about any firm conclusions because of
heterogeneity in reference groups and exposure definitions.
Misclassification seems to be a large problem in these studies
due to imprecise or vague definitions of insufficient milk supply. In
these studies, the percentage of cases reporting insufficient milk
supply ranged from 7–61%. They reported a wide range of results,
with estimates of the effect of insufficient milk supply on breast
cancer risk ranging from null effects to an odds ratio over 16.
Interpretation of Between-Study Differences
The use of different reference groups was an important source
of heterogeneity among studies in this review. Byers, Shema, and
Yang’s studies all found that insufficient milk supply was a
significant risk factor for premenopausal breast cancer [15,20,21].
The comparison groups in each of these studies were women who
breastfed successfully for various lengths of time. While not all
studies have reported protective effects [25,26], meta-analysis has
demonstrated a reduced risk of breast cancer among women who
breastfed their infants [12]; therefore, any harmful effect of
insufficient milk supply observed could also be explained as a
protective effect of prolonged breastfeeding in the reference group
consisting of women with a sufficient milk supply. Women who
never breastfed may provide a more appropriate comparison
group; however, women who choose not to breastfeed their
children may have an overall less healthy lifestyle and this may
introduce bias (confounding) into the results of the association
between insufficient milk supply and breast cancer.
Brinton and Yang both chose comparison groups that seemed
to be a good compromise between avoiding bias due to the
protection afforded by breastfeeding and avoiding unmeasured
confounders among women who chose not to breastfeed their
infants [18,20]. Yang’s comparison group comprised women who
intended to breastfeed and then stopped because of factors other
than insufficient milk supply before one month had elapsed since
delivery [20]. Brinton made a similar comparison, however chose
women who stopped breastfeeding at less than two weeks [18].
Although these comparisons were interesting, these women are
rare and therefore limit sample sizes and the power to detect
significant associations.
In addition to the heterogeneity of reference groups, the lack of
a clear and consistent definition of insufficient milk supply in these
studies was also a cause of concern. Insufficient milk supply may be
caused by a variety of factors and has repeatedly been cited in the
literature as a common reason that women stop breastfeeding
[27,28]. Iatrogenic causes and mismanagement of breastfeeding
such as strictly scheduled feeding times and infrequent nursing are
among the most common causes of insufficient milk supply [28].
Insufficient mammary glandular tissue, a primary cause of
insufficient milk supply, is a rare phenomenon. Based on a
prospective study of 319 healthy, motivated, primiparous women
with healthy, term infants who received intensive intervention with
a lactation consultant, it was estimated that 4 percent of the cases
of insufficient milk supply were attributable to a primary problem
of the breast due to the lack of sufficient glandular tissue available
for milk production [29,30]. Since this cause of insufficient milk
supply most closely resembles the phenotype observed in mice
with overexpression of PTP1B [8], it is important that studies
examining a link between insufficient milk supply and breast
cancer focus on this group of women who suffer from an organic
problem of the breast, as opposed to insufficient milk resulting
from a potentially modifiable factor.
In the studies reviewed, however, the definitions of insufficient
milk supply utilized were often non-specific. According to Byers’
definition, a woman could report having experienced insufficient
milk supply at any time after her first birth. Women have often
misinterpreted the physiologic decreases in milk supply that occur
over time to be symptoms of insufficient milk supply. The use of
this exposure definition will most likely result in many more
exposed subjects than would be predicted based on the reported
prevalence of this problem. Indeed, 61% of premenopausal cases
and 42% of premenopausal controls in Byer’s study reported
experience of insufficient milk supply [21]. Although our
hypothesis would suggest a higher rate of insufficient milk supply
among breast cancer cases than in the general population, we
would still expect a much lower proportion than that which was
reported from this study. According to Brinton’s exposure
definition, a woman could report having experienced insufficient
milk supply as a reason for quitting breastfeeding in the first two
weeks postpartum [18]. Use of this definition will probably lead to
the inclusion of women who have experienced delayed lactogen-
esis but not necessarily persistent insufficient milk supply; when
women stop breastfeeding before two weeks it is likely that this is
due to very early breastfeeding troubles, therefore, there is also a
Table 2. Characteristics of studies investigating an association between insufficient milk supply and breast cancer.
Author Year of Publication Country Study Period Outcome (type of breast cancer) Age (years) N total
Shema [15] 2007 Israel 2005 premenopausal and postmenopausal 30–75 640
Newcomb [16] 1999 U.S.A. 1992–1994 postmenopausal 50–79 1323
Freudenheim [17] 1997 U.S.A. not available premenopausal and postmenopausal 40–85 511
Brinton [18] 1995 U.S.A. not available premenopausal ,45 169
Newcomb [19] 1994 U.S.A. not available premenopausal and postmenopausal ,75 7454
Yang [20] 1993 Canada 1988–1989 premenopausal and postmenopausal ,75 1182
Byers [21] 1985 U.S.A. 1957–1965 premenopausal and postmenopausal 40–84 1012
*note that all are case-control studies.
doi:10.1371/journal.pone.0008237.t002
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definition. The best definitions were in Shema and Yang’s studies
(Table 2) which both focused on the first month after birth [15,20].
The use of non-specific definitions of insufficient milk supply
likely lead to important misclassification of the exposure. If both
cases and controls equally misclassified themselves as having
experienced insufficient milk supply, it is possible that the true
association between insufficient milk supply and breast cancer is
stronger than that which was found in some of these studies.
However, as it is common in case-control studies for cases to over
report exposures which they think may be involved in the causal
pathway of their disease, it is also possible that differential
misclassification could have led to bias towards a positive
association.
Limitations
There were some limitations in this review. Only English studies
were included for the database search for 2006–2008. It is unlikely
that this introduced a meaningful amount of bias. In the Berrino
review, which covered the longest time (from 1966–2006) few
studies in other languages were identifiedand were then excluded in
our review process. It was unfeasible to include unpublished data
and therefore the possibility for publication bias exists. Because this
association was often not the main focus of the included papers, the
problem may be important as the results may not have been
presented if there was an otherwise uninteresting result. However,
based on the studies reviewed here, it does not appear that only
positive findings are being published. Only one reviewer was
involved in the search and selection of studies, which is another
potential limitation of this review, but the majority of studies
included in the secondary screen were derived from a systematic
review in which the studies had been selected in duplicate.
Meta-analysis is not conventionally carried out in cases where
heterogeneity statistics reveal a great deal of variability in study
findings, as was observed among the included studies. However,
studies addressing the risk of breast cancer in premenopausal
women obtained either null or positive findings. We chose to
calculate pooled estimates despite heterogeneity, because it was
likely that the tests were significant because of widely different
magnitudes of the positive effect estimates as opposed to
differences in the direction of the effect estimates. The strength
of evidence provided by these meta-analyses is admittedly weak
because of small sample sizes and widely varied estimates of the
association between insufficient milk supply and breast cancer;
however, we felt it was important to provide a summary of the
effect according to the evidence presented in this review.
Recommendations for Future Research
In future studies of premenopausal breast cancer, a more
specific definition of insufficient milk supply should be used.
Interview questions should attempt to identify women with
problems breastfeeding whose problems arose at the level of the
breast and not from mismanagement of breastfeeding or hormonal
imbalance. Follow-up questions should be designed so as to
narrow the focus on women who intended to breastfeed but could
not do so successfully without supplementing with formula due to
poor infant weight gain. It may also be useful to rule out
breastfeeding difficulties that were due to the infant’s inability to
effectively transfer milk from the breast.
A major concern for the design of future studies is that both the
exposure and the outcome are rare events among premenopausal
women. In a case-control study of women with breast cancer, it is
unlikely that many of these women would have experienced
primary insufficient milk supply due to its low incidence rate,
requiring a large sample size. Nevertheless, case-control studies
evaluating breast cancer risk may be the most effective approach
as multiple risk factors may be examined in one study and cohort
studies are less efficient for rare events.
Figure 2. Odds ratios and 95% confidence intervals from studies ordered by quality of exposure definition. Forest plots of the odds
ratios (ORs) and confidence intervals (CIs) for the risk of premenopausal breast cancer (left plot) and postmenopausal breast cancer among women
who experienced insufficient milk supply compared to women who breastfed successfully, or in the case of Brinton et al, stopped breastfeeding
before 2 weeks for reasons other than insufficient milk supply. Note that high quality exposure definitions correspond to lower values on the y-axis.
doi:10.1371/journal.pone.0008237.g002
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No consistent convincing evidence of a link between insufficient
milk supply and breast cancer was found. Despite heterogeneous
findings of individual studies, a summary of studies comparing
women with premenopausal breast cancer with women who
successfully breastfed for various lengths of time, however,
indicated significantly increased risks of breast cancer among
women who experienced insufficient milk supply. More research is
needed to determine if a true effect exists, while taking into
consideration the importance of the choice of comparison group
and the definition of insufficient milk supply. The focus of future
research should be on women who do not produce enough breast
milk and whose problems cannot be alleviated with current
therapies or changes in breastfeeding behavior.
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